Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q2 2013 Earnings

8AugExpected
Q3 2012
Q4 2012
Q1 2013
Q2 2013
-13,020
-9,013
-5,006
-999

Details

Expected EPS
-11606
Actual EPS
-7560
Surprise EPS
4,046
Surprise Percent
+34.86%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -7560 per share for Q2 2013.

0 Comments

Share your thoughts